🌍 17 webinars. 4,631 registrations. Participants from 128 countries. Our 2025 @efisg-escmid.bsky.social series shows the power of digital education to expand global access to expertise in medical mycology. 🍄📚 www.sciencedirect.com/science/arti...

#ESGBIES #EFISG #ESGICH survey on the management of organ donors colonized or infected with Candidozyma auris > Anonymous survey >Only 5–7 minutes to answer 🔗 docs.google.com/forms/d/e/1F... Please complete it only once!

Current practices regarding the use of organs from donors colonized or infected with Candidozyma auris: a multinational survey of solid organ transplant centres

Dear colleague, We are conducting a multinational survey to assess current clinical practices regarding the acceptance and management of organs from donors colonized or infected with Candidozyma auris...

docs.google.com

Timely diagnosis of invasive mycoses saves lives 🦠 @efisg-escmid.bsky.social study reveals disparities in access to diagnostics and therapies across #LATAM #Caribbean, highlighting urgent need to strengthen laboratory capacity and improve access to essential drugs www.nature.com/articles/s41...

NEXT EFISG WEBINAR | 30 July 2026 | 16:00 CET The Dual-Use Dilemma: Protecting Frontline Clinical Medicines through Fungicide Policy Development Chair: M. Bottery Speakers: M. Bottery, A. Brown, R. Bryson, S. Weeks ➡️ us06web.zoom.us/webinar/register/WN_RfkYHMCaQKmAWOExiO95Rw#/registration

Welcome! You are invited to join a webinar: EFISG: The Dual-Use Dilemma: Protecting Frontline Clinical Medicines through Fungicide Policy Development. After registering, you will receive a confirmatio...

Speaker 1 The Dual-Use Dilemma: Protecting Frontline Clinical Medicines through Fungicide Policy Development Michael Bottery Speaker 2 The Dual-Use Dilemma: Protecting Frontline Clinical Medicin...

us06web.zoom.us

🆕@efisg publication... In 1,132 adults ≥65 with #Candida bloodstream infection, biological sex did not affect 30-day mortality. Prognosis depended on age, comorbidities, septic shock, and source control. www.sciencedirect.com/science/arti...

📢 Working in #MedicalMycology? Take a global, anonymous survey on career development + workplace experiences. Open to clinicians, scientists, veterinarians, pharmacists, trainees, and all career stages worldwide. ⏱️ ~11 min | 📅 Closes 31 July 2026 👉 www.clinicalsurveys.net/uc/wim-womyc...

📢 Call for Applications! 🍄 Become the next TAE Representative in the ESCMID Fungal Infection Study Group (EFISG) for 2026–2028! 🔹 Requisite: Active ESCMID Young Scientist Member Apply now (CV + short text) 👇 🔗 docs.google.com/forms/d/e/1F...

🎉 #EFISG has outgrown its #WhatsApp group! We hit the 1,024-member limit and have now moved to a new community with space for 2,000 members. Join us: chat.whatsapp.com/Gy0O8KmiznIF...

EFISG Updates

WhatsApp Group Invite

chat.whatsapp.com

New #EFISG Board members 2026-2028 @salmantongarcia.bsky.social – Chair Riina Richardson – Treasurer Dionysios Neofytos– Secretary Claudia Bartalucci– Educational Officer Zoi Dorothea Pana – Scientific Officer @escmid.bsky.social

📢 NEXT EFISG + MMIG Webinar 🗓 20 May | ⏰ 08:00 CET 🔗 Register here: uni-koeln.zoom.us/meeting/regi... Topics – Epidemiology and clinical presentation – Case-based discussion of invasive aspergillosis – European perspective on management of invasive aspergillosis

New accepted manuscript from hashtag #EFISG! 🌍🧫 “Profiling medical mycologists: Results from a global survey of the ESCMID Fungal Infection Study Group” academic.oup.com/mmy/advance-...

Profiling medical mycologists: Results from a global survey of the ESCMID Fungal Infection Study Group (EFISG)

Abstract. Invasive fungal infections (IFI) are a major cause of morbi-mortality, particularly in immunocompromised and critically ill patients. Increasing

academic.oup.com

📢 𝐄𝐅𝐈𝐒𝐆 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐌𝐞𝐞𝐭𝐢𝐧𝐠 🗓 Monday, 20 April 2026 ⏰ 16:15–17:15 CET 📍 ICM 4 (ESCMID Global in Munich) + key4events.zoom.us/j/85290315683?pwd=ydbah1cboY2Z43NtobRMvZ3CEsGuDN.1 🎁 EFISG pins will be available, grab yours!

EFISG Newsletter – Spring 2026 out! 🔹 Call for proposals for ESCMID Global 2027 👉 www.clinicalsurveys.net/uc/ESCMIDGlo... 🔹 Business Meeting 📅 20 April | ⏰ 16:15–17:15 CET | 📍 ICM 4 🔹 Call for new projects ➡️ Submit proposal-slides by Apr 13 to efisg.sg@gmail.com www.escmid.org/fileadmin/es...

25 March 2026 at 08:00 CET Candida Endocarditis: when yeast meets the heart uni-koeln.zoom.us/meeting/regi...

Info for registered EFISG members: Voting for EFISG Board ('26–'28) is open until March 2nd To vote: Log in at my.escmid.org 🖱️“Study group elections” 🖱️“ESCMID Fungal Infection Study Group (EFISG) [Election open]” 🖱️“Vote ballot” 🖱️Candidate(s) and click “VOTE”

Info for registered EFISG members: Voting for EFISG Board ('26–'28) is open until March 2nd To vote: Log in at my.escmid.org 🖱️“Study group elections” 🖱️“ESCMID Fungal Infection Study Group (EFISG) [Election open]” 🖱️“Vote ballot” 🖱️Candidate(s) and click “VOTE”

TODAY! In 8 hours! us06web.zoom.us/webinar/regi...

Welcome! You are invited to join a webinar: EFISG: Women in Science (Mycology) – Past, Present, and Future. After registering, you will receive a confirmation email about joining the webinar.

Chairs: Ana Alastruey-Izquierdo (ES) & Sevtap Arikan-Akdagli (TR) Speakers: "The First" - Esther Segal "The Ghost of the Past" - Cornelia Lass-Flörl "The Ghost of the Present" - Sarah Dellière "The ...

us06web.zoom.us

ESCMID Fungal Infection Study Group (EFISG)@efisg-escmid.bsky.social · 8mo ago

Past, present and future of fungal research at @ESCMID #EFISG webinar Women in Science (Mycology)🗓️ 11 Feb 2026 | 18:00 CET E. Segal C. Lass-Flörl S. Dellière L. Martín-Souto 🔗 Free registration: us06web.zoom.us/webinar/regi...

Past, present and future of fungal research at @ESCMID #EFISG webinar Women in Science (Mycology)🗓️ 11 Feb 2026 | 18:00 CET E. Segal C. Lass-Flörl S. Dellière L. Martín-Souto 🔗 Free registration: us06web.zoom.us/webinar/regi...

If you are a member of the Young ISHAM community, the ISHAM council has exciting news for you... @olivercornely.bsky.social @neil-gow.bsky.social @youngecmm.bsky.social @efisg-escmid.bsky.social

@efisg-escmid.bsky.social webinar! 11 February - 18.00 CET Registration: us06web.zoom.us/webinar/regi...

Emerging terbinafine-resistant Trichophyton indotineae between 2018 and 2023: a multinational genomic epidemiology study - The Lancet Microbe www.thelancet.com/journals/lan...

Emerging terbinafine-resistant Trichophyton indotineae between 2018 and 2023: a multinational genomic epidemiology study

That no clear geographical clustering of isolates was observed confirms the rapid transcontinental spread of T indotineae from its likely centre of diversity in Asia. Our findings highlight the import...

thelancet.com

#EFISG webinars January - April 2026 More info: www.escmid.org/efisg @escmid.bsky.social @taescmid.bsky.social

👉📅 February 4, 2026 🧫🌎 @APInfectologia webinar | #Aspergillosis in #LATAM in #Spanish 📺 Live on YouTube... youtube.com/@API_ok 16:00 GT, CR 17:00 CO, PE, EC 18:00 VE, PA 19:00 UY, AR, BR 23:00 ES

📅 Jan 20 | 11:00 CET - Evolving fungal names: What clinicians and scientists need to know Ferry Hagen🇳🇱 Andy Borman🇬🇧 Sarah Kidd🇦🇺 📅 Feb 17 | 15:00 CET - Point-of-care diagnostics in IFD Robina Aerts🇧🇪 Tsidiso Maphanga🇿🇦 www.escmid.org/efisg/ "Webinars" @escmid.bsky.social @taescmid.bsky.social

Nomination phase for EFISG Board ('26–'28) open from 06-01 to 02-02. Each candidate requires support from two EFISG members. To nominate: my.escmid.org → SG elections → EFISG → Support members Good luck to all candidates!

New nationwide ESCMID-EFISG study on fungal infection care in Colombia: major gaps in diagnostics, limited access to advanced tools & antifungals, with strong urban–rural disparities. www.sciencedirect.com/science/arti... @salmantongarcia.bsky.social @escmid.bsky.social @efisg-escmid.bsky.social

Diagnostic and therapeutic capacity for fungal infections in Colombia: An ESCMID-EFISG nationwide multicenter assessment of mycological healthcare

This study aims to evaluate nationwide diagnostic and treatment capacity for IFD across Colombia’s diverse healthcare system.Between March and Septemb…

sciencedirect.com

#EFISG webinars and more... www.clinicalsurveys.net/uc/EFISG_web... 2025 18/11, +@ESGAP_ABS Antifungal stewardship 11–12/12, XII Mycological Forum🇪🇸 16/12, Dermatophytes dx and tx 17/12, Dengue in hem/onc 22/12, IDWeek and CHEST hightlights 2026 20/01, Taxonomy 17/01, Point-of-care dx

TOMORROW 📅 15:00 CET ESGAP + EFISG WEBINAR Let’s go mushrooming! – An antifungal stewardship talk show 🎤 L. Bussini, IT – AF stewardship in immunosuppressed patients L. Kriegl, AT – AF stewardship in the era of new agents 🔗 Register here: us06web.zoom.us/webinar/regi...

Welcome! You are invited to join a webinar: ESGAP & EFISG: Let's go Mushrooming! - An antifungal Stewardship talk show. After registering, you will receive a confirmation email about joining the webin...

Welcome! You are invited to join a webinar: ESGAP & EFISG: Let's go Mushrooming! - An antifungal Stewardship talk show. After registering, you will receive a confirmation email about joining the webin...

us06web.zoom.us

ESCMID Fungal Infection Study Group (EFISG)@efisg-escmid.bsky.social · 11mo ago

#EFISG webinars and more... www.clinicalsurveys.net/uc/EFISG_web... 2025 18/11, +@ESGAP_ABS Antifungal stewardship 11–12/12, XII Mycological Forum🇪🇸 16/12, Dermatophytes dx and tx 17/12, Dengue in hem/onc 22/12, IDWeek and CHEST hightlights 2026 20/01, Taxonomy 17/01, Point-of-care dx

Our joint ISAC / ESCMID webinar tackled challenges from the WHO #Fungal Priority Pathogen List: ✅ Azole-resistant Aspergillus fumigatus ✅ Antifungal resistance in Candida ✅ Urgent need for better diagnostics & management 🎥 Watch now youtu.be/MCRZ5OAaZaE @efisg-escmid.bsky.social @escmid.bsky.social

#EFISG webinars and more... www.clinicalsurveys.net/uc/EFISG_web... 2025 18/11, +@ESGAP_ABS Antifungal stewardship 11–12/12, XII Mycological Forum🇪🇸 16/12, Dermatophytes dx and tx 17/12, Dengue in hem/onc 22/12, IDWeek and CHEST hightlights 2026 20/01, Taxonomy 17/01, Point-of-care dx